Rule 44 – Contents of the Statement for revocation
Content
The claimant shall, subject to point (b), lodge a Statement for revocation at the Registry in accordance
with Article 7(2) of the Agreement and Annex II thereto. The Statement for revocation shall contain:
(a) particulars in accordance with Rule 13.1(a) to (d) and (g), (h);
(b) where the parties have agreed to bring the action before a local division or a regional division in
accordance with Article 33(7) of the Agreement, an indication of the division which shall hear the action,
accompanied by evidence of the defendant’s agreement;
(c) where applicable, an indication that the action shall be heard by a single judge [Article 8(7) of the
Agreement], accompanied by evidence of the defendant’s agreement;
(d) an indication of the extent to which revocation of the patent is requested;
(e) one or more grounds for revocation, which shall as far as possible be supported by arguments of law,
and where appropriate an explanation of the claimant’s proposed claim construction;
(f) an indication of the facts relied on;
(g) the evidence relied on, where available, and an indication of any further evidence which will be
offered in support;
(h) an indication of any order the claimant will seek during the interim procedure [Rule 104(e)];
and
(i) a list of the documents, including any witness statements, referred to in the Statement
for revocation together with any request that all or part of any such document need not be
translated and/or any request pursuant to Rule 262.2 and Rule 262A. Rule 13.2 and .3 shall apply mutatis
mutandis.
Related Cases
- UPC_ CFI_860/2025 – LS v Bellissa
- UPC_CoA_71/2025 – VMR v NJOY
- UPC_CoA_464/2024, UPC_CoA_457/2024, UPC_CoA_458/2024, UPC_CoA_530/2024, UPC_CoA_532/2024, UPC_CoA_533/2024, UPC_CoA_21/2025, UPC_CoA_27/2025 – Meril v Edwards
- UPC_CFI_497/2024 – bioMérieux v Labrador
- UPC_CFI_189/2024; UPC_CFI_434/2024 – Meril v Edwards
- UPC_CFI_315/2023 – NJOY vs Juul Labs
- UPC_CFI_198/2024 – Aylo v Dish
- UPC CoA 464/2024, UPC CoA 530/2024, UPC CoA 21/2025, UPC CoA 457/2024, UPC CoA 532/2024, UPC CoA 27/2025, UPC CoA 458/2024, UPC CoA 533/2024 – Edwards Lifesciences Corporation v Meril